cui1,cui2,relation,name1,name2,type1,type2,weight,predicate
C0001551,C0018270,NEG_AFFECTS,Immunologic Adjuvants,Growth,imft,orgf,1,NEG_AFFECTS_IMFTnafctORGF
C0003316,C0018270,NEG_AFFECTS,Epitopes,Growth,imft,orgf,1,NEG_AFFECTS_IMFTnafctORGF
C0003320,C0018270,NEG_AFFECTS,Antigens,Growth,imft,orgf,2,NEG_AFFECTS_IMFTnafctORGF
C0003320,C0678889,NEG_AFFECTS,Antigens,Immunoregulation,imft,orgf,1,NEG_AFFECTS_IMFTnafctORGF
C0003320,C1155328,NEG_AFFECTS,Antigens,Antiviral Response,imft,orgf,1,NEG_AFFECTS_IMFTnafctORGF
C0042212,C0020966,NEG_AFFECTS,"Vaccines, Inactivated",Cellular Immunity,imft,orgf,1,NEG_AFFECTS_IMFTnafctORGF
C0062086,C1516559,NEG_AFFECTS,Haemophilus influenzae type b polysaccharide vaccine,Circulatory Process,imft,orgf,1,NEG_AFFECTS_IMFTnafctORGF
C2825347,C0678210,NEG_AFFECTS,"immunoglobulin A, human","Passive immunity, function",imft,orgf,1,NEG_AFFECTS_IMFTnafctORGF
